Loading organizations...
Kidron Capital Assets is a Tel Aviv, Israel-based venture capital firm that invests in untapped women's health opportunities across various indications, modalities, and key geographies. The firm focuses on health tech companies leveraging patient data analytics for predictive, preventive, and precision healthcare, addressing unmet medical needs in the sector. Kidron Capital manages one fund and has made inaugural investments in US-based companies such as Beyond Medicine, Portal, and Renal Guard. Its leadership includes Founding and Managing Partner Maria Gajda Horowitz and Co-Founding and Managing Partner Anula Jayasuriya, alongside Vice President of Business Development J. Harris Gollin. Kidron Capital Assets was founded in 2021 by Maria Gajda Horowitz and Anula Jayasuriya. Its business model centers on venture capital fund raising capital from investors to deploy into women's health startups, with a first close announced for its debut fund.
Kidron Capital Assets has 2 tracked investments across 2 companies. The latest tracked deal is $25.0M Series B in May Health in May 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2024 | May Health | $25.0M Series B | Jean François Morin, Nina Rawal | Cathay Health, Endeavor Venture Funds, NEW Enterprise Associates (NEA), Soffinova Partners, Sonder Capital, Avestria Ventures |
| Oct 1, 2009 | Cambrios Technologies | $15.0M Series D | — | Waverley Capital, Alexandria Venture Investments, Alloy Ventures, Altitude Life Science Ventures, ARCH Venture Partners, Avalon Ventures, Michael Knapp, Chisso Corporation, Harris & Harris Group, Headland Ventures, IN Q TEL, LUX Capital, Mitsubishi UFJ Capital, Nissha Printing, Oxford Bioscience Partners, Presidio Ventures, Sumitomo Corporation |
